Literature DB >> 19452343

Use of respiratory function tests to predict survival in amyotrophic lateral sclerosis.

Fusun Baumann1, Robert D Henderson, Stephen C Morrison, Michael Brown, N Hutchinson, James A Douglas, Peter J Robinson, Pamela A McCombe.   

Abstract

Respiratory function tests (RFTs) are commonly used as a measure of progression in ALS. This study assessed the ability of various RFTs to predict survival in ALS patients. Subjects with ALS had one or more measurements of seated and supine FVC, maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP). Kaplan-Meier (KM) analysis was used to determine whether patients with abnormal RFTs had shorter survival than those with normal RFTs. The sensitivity and specificity of RFTs as predictors of two-year survival were calculated from receiver operating characteristic (ROC) curves. With KM analysis, subjects with abnormal values of seated FVC, supine FVC, MIP and MEP had significantly reduced survival compared to subjects with normal values. With ROC curves, a normal supine FVC was highly predictive for two-year survival and had superior sensitivity over seated FVC. Slower rates of decline in seated or supine FVC were strong predictors of two-year survival. Our study demonstrates that respiratory function measurements are useful to predict survival in ALS patients. We show that measurements of FVC in the supine position are worth including in the assessment of respiratory function in ALS.

Entities:  

Mesh:

Year:  2010        PMID: 19452343     DOI: 10.3109/17482960902991773

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN: 1471-180X


  22 in total

1.  Association Between Decline in Slow Vital Capacity and Respiratory Insufficiency, Use of Assisted Ventilation, Tracheostomy, or Death in Patients With Amyotrophic Lateral Sclerosis.

Authors:  Jinsy A Andrews; Lisa Meng; Sarah F Kulke; Stacy A Rudnicki; Andrew A Wolff; Michael E Bozik; Fady I Malik; Jeremy M Shefner
Journal:  JAMA Neurol       Date:  2018-01-01       Impact factor: 18.302

2.  A cross-sectional analysis of clinical evaluation in 35 individuals with mutations of the valosin-containing protein gene.

Authors:  Jake Plewa; Abhilasha Surampalli; Marie Wencel; Merit Milad; Sandra Donkervoort; Vincent J Caiozzo; Namita Goyal; Tahseen Mozaffar; Virginia Kimonis
Journal:  Neuromuscul Disord       Date:  2018-06-27       Impact factor: 4.296

3.  Respiratory and nutritional support in amyotrophic lateral sclerosis.

Authors:  Namita A Goyal; Tahseen Mozaffar
Journal:  Curr Treat Options Neurol       Date:  2014-02       Impact factor: 3.598

4.  Prognostic role of slow vital capacity in amyotrophic lateral sclerosis.

Authors:  Andrea Calvo; Rosario Vasta; Cristina Moglia; Enrico Matteoni; Antonio Canosa; Alessio Mattei; Claudio La Mancusa; Luana Focaraccio; Letizia Mazzini; Adriano Chiò; Fabrizio D'Ovidio; Umberto Manera
Journal:  J Neurol       Date:  2020-02-12       Impact factor: 4.849

5.  Sniff nasal inspiratory pressure as a prognostic factor of tracheostomy or death in amyotrophic lateral sclerosis.

Authors:  Rosa Capozzo; Vitaliano N Quaranta; Fabio Pellegrini; Andrea Fontana; Massimiliano Copetti; Pierluigi Carratù; Francesco Panza; Anna Cassano; Vito A Falcone; Rosanna Tortelli; Rosa Cortese; Isabella L Simone; Onofrio Resta; Giancarlo Logroscino
Journal:  J Neurol       Date:  2014-12-19       Impact factor: 4.849

Review 6.  Management of respiratory symptoms in ALS.

Authors:  Orla Hardiman
Journal:  J Neurol       Date:  2010-11-17       Impact factor: 4.849

7.  Acute intermittent hypoxia and respiratory muscle recruitment in people with amyotrophic lateral sclerosis: A preliminary study.

Authors:  Elaheh Sajjadi; Yasin B Seven; Jessica G Ehrbar; James P Wymer; Gordon S Mitchell; Barbara K Smith
Journal:  Exp Neurol       Date:  2021-10-06       Impact factor: 5.620

Review 8.  Developmental and Functional Effects of Steroid Hormones on the Neuroendocrine Axis and Spinal Cord.

Authors:  L Zubeldia-Brenner; C E Roselli; S E Recabarren; M C Gonzalez Deniselle; H E Lara
Journal:  J Neuroendocrinol       Date:  2016-07       Impact factor: 3.627

Review 9.  The Role of immune and inflammatory mechanisms in ALS.

Authors:  P A McCombe; R D Henderson
Journal:  Curr Mol Med       Date:  2011-04       Impact factor: 2.222

10.  Riluzole and prognostic factors in amyotrophic lateral sclerosis long-term and short-term survival: a population-based study of 1149 cases in Taiwan.

Authors:  Charles Tzu-Chi Lee; Yi-Wen Chiu; Kai-Chen Wang; Chi-Shin Hwang; Kuan-Hsiang Lin; I-Ta Lee; Ching-Piao Tsai
Journal:  J Epidemiol       Date:  2012-10-27       Impact factor: 3.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.